Business
Risks Related to our Platform and Data ● Our business and operations would suffer in the event of computer system failures, cyber-attacks, or deficiencies in our or our third parties' cybersecurity.
Journey Medical Corp: Revenue grew 11.1% to $61.24M from $55.13M. Net loss narrowed to $11.43M from $14.67M. Operating cash flow outflow widened to $12.44M from $9.127M. Operating margin expanded 1147 bps to -13.34%. Journey Medical Corp's annual comparison also shows the manipulation screen is flagged and should be investigated as a warning rather than treated as proof; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 11.1% to $61.24M from $55.13MOK
- Profitability — Net loss narrowed to $11.43M from $14.67MOK
- Cash flow — Operating cash flow outflow widened to $12.44M from $9.127MNote
- Margins — Operating margin expanded 1147 bps to -13.34%OK
- Accounting — Going-concern warningWatch
- Insiders — 0 purchases and 0 salesNote
Where the revenue comes from
Fiscal 2025, as Journey Medical Corp reports it. History and quarterly detail are in the app.
- Qbrexza$25.0M
- Emrosi$14.7M
- Accutane$12.9M
- Foam Franchise Products Amzeeq Zilxi$5.9M
- Other Legacy$2.7M
Leadership changes
From Journey Medical Corp's own filings, the day they're filed.
- Ramsey Alloush · Chief Operating Officer · appointmenteff. 2025-04-01
- Joseph Benesch · Chief Financial Officer · appointmenteff. 2023-01-27
- Michael C. Pearce · appointment
Latest filings
- 8-K · Company announcement2026-08-12
- 10-Q · Quarterly report2026-08-12
- 8-K · Company announcement2026-06-26
- 8-K · Company announcement2026-05-13
- 10-Q · Quarterly report2026-05-13
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Journey Medical Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.